PMID- 30509964 OWN - NLM STAT- MEDLINE DCOM- 20190729 LR - 20221207 IS - 1573-4935 (Electronic) IS - 0144-8463 (Print) IS - 0144-8463 (Linking) VI - 39 IP - 1 DP - 2019 Jan 31 TI - A trial sequential meta-analysis of TNF-alpha -308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer. LID - BSR20181052 [pii] LID - 10.1042/BSR20181052 [doi] AB - PURPOSE: Tumor necrosis factor-alpha (TNF-alpha), secreted by the activated macrophages, may participate in the onset and progression of colorectal cancer (CRC). The association of TNF-alpha -308 G>A (rs1800629) single-nucleotide polymorphism (SNP) with CRC risk has been investigated by many studies but the results are inconclusive. A trial sequential meta-analysis was performed for precise estimation of the relationship between TNF-alpha -308 G>A gene polymorphism with CRC risk. METHODS: Medline (PubMed), EMBASE (Excerpta-Medica) and Google Scholar were mined for relevant articles. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the significance of association. RESULTS: The pooled analysis indicated no risk associated with TNF-alpha -308 G>A SNP and overall CRC risk in five genetic comparison models, i.e. allelic (A vs. G: P = 0.524; OR = 1.074, 95% CI = 0.863-1.335), homozygous (AA vs. GG: P = 0.489; OR = 1.227, 95% CI = 0.688-2.188), heterozygous (AG vs. GG: P = 0.811; OR = 1.024, 95% CI = 0.843-1.244), dominant (AA+AG vs. GG: P = 0.630; OR = 1.055, 95% CI = 0.849-1.311) and recessive (AA vs. AG+GG: P = 0.549; OR = 1.181, 95% CI = 0.686-2.033). Subgroup analysis revealed that TNF-alpha -308 G>A SNP is associated with reduced risk of CRC in Asian ethnicity. The study showed no publication bias. CONCLUSIONS: No association of TNF-alpha -308 G>A SNP with overall CRC risk was found. This SNP is likely to be protective against CRC in Asian population when compared with Caucasian population. Larger prospective-epidemiological studies are warranted to elucidate the roles of TNF-alpha -308 G>A SNP in the etiology of CRC and to endorse the present findings. CI - (c) 2019 The Author(s). FAU - Mandal, Raju K AU - Mandal RK AD - Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia. FAU - Khan, Munawwar Ali AU - Khan MA AD - Department of Life and Environmental Sciences, College of Natural and Health Sciences, Zayed University, P.O. Box 19282, Dubai, United Arab Emirates. FAU - Hussain, Arif AU - Hussain A AD - School of Life Sciences, Manipal Academy of Higher Education, P.O. Box 345050, Dubai, United Arab Emirates. FAU - Akhter, Naseem AU - Akhter N AD - Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Albaha University, Albaha 65431, Saudi Arabia. FAU - Jawed, Arshad AU - Jawed A AD - Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia. FAU - Dar, Sajad A AU - Dar SA AD - Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia. FAU - Wahid, Mohd AU - Wahid M AD - Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia. FAU - Panda, Aditya K AU - Panda AK AD - Centre for Life Sciences, Central University of Jharkhand, Ranchi 835205, Jharkhand, India. FAU - Lohani, Mohtashim AU - Lohani M AD - Department of Emergency Medical Services, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia. FAU - Mishra, Bhartendu N AU - Mishra BN AD - Department of Biotechnology, Institute of Engineering and Technology, Lucknow 226021, Uttar Pradesh, India. FAU - Haque, Shafiul AU - Haque S AUID- ORCID: 0000-0002-2989-121X AD - Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia shafiul.haque@hotmail.com. LA - eng PT - Journal Article PT - Meta-Analysis DEP - 20190115 PL - England TA - Biosci Rep JT - Bioscience reports JID - 8102797 RN - 0 (Tumor Necrosis Factor-alpha) MH - Asian People MH - Clinical Trials as Topic MH - Colorectal Neoplasms/diagnosis/ethnology/*genetics/pathology MH - Gene Expression MH - Genotype MH - Heterozygote MH - Homozygote MH - Humans MH - Models, Genetic MH - Odds Ratio MH - *Polymorphism, Single Nucleotide MH - *Promoter Regions, Genetic MH - Tumor Necrosis Factor-alpha/*genetics MH - White People PMC - PMC6331670 OTO - NOTNLM OT - Colorectal cancer OT - Meta-analysis OT - Tumor Necrosis Factor-alpha OT - polymorphism OT - susceptibility COIS- The authors declare that there are no competing interests associated with the manuscript. EDAT- 2018/12/05 06:00 MHDA- 2019/07/30 06:00 PMCR- 2019/01/15 CRDT- 2018/12/05 06:00 PHST- 2018/06/29 00:00 [received] PHST- 2018/10/29 00:00 [revised] PHST- 2018/11/29 00:00 [accepted] PHST- 2018/12/05 06:00 [pubmed] PHST- 2019/07/30 06:00 [medline] PHST- 2018/12/05 06:00 [entrez] PHST- 2019/01/15 00:00 [pmc-release] AID - BSR20181052 [pii] AID - 10.1042/BSR20181052 [doi] PST - epublish SO - Biosci Rep. 2019 Jan 15;39(1):BSR20181052. doi: 10.1042/BSR20181052. Print 2019 Jan 31.